Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Virogates

8.44

 

DKK

 

+3.94 %

Less than 1K followers

VIRO

First North Denmark

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Compare
+3.94%
+29.45%
-6.22%
-20.38%
-38.39%
+8.21%
-87.7%
-81.76%
-87.2%

Virogates is a medical technology company. Business operations are conducted within the research and development of biomarkers and diagnostic instruments for the healthcare industry. The products are sold under various brands and are used in the identification, analysis, and further treatment of diseases, mainly cardiovascular diseases, cancer, and neurological diseases. The company was established in 2001 and is headquartered in Birkerød.

Read more
Market cap
65.3M DKK
Turnover
26.66K DKK
Revenue
4.9M
EBIT %
-297.14 %
P/E
-
Dividend yield-%
-
Financial calendar
21.8
2025

Interim report Q2'25

6.11
2025

Interim report Q3'25

All
Research
Press releases
3rd party
ShowingAll content types
Regulatory press release5/21/2025, 2:16 PM

Resolutions from the Extraordinary General Meeting of ViroGates A/S

Virogates
Regulatory press release5/6/2025, 9:55 AM

ViroGates gives notice to convene an Extraordinary General Meeting on 21 May 2025

Virogates
Regulatory press release5/1/2025, 3:39 PM

ViroGates announces its Q1 report for 2025

Virogates

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/24/2025, 7:17 PM

Resolutions from the Annual General Meeting of ViroGates A/S

Virogates
Regulatory press release4/7/2025, 11:25 AM

Notice to convene the annual general assembly

Virogates
Regulatory press release3/20/2025, 6:23 PM

ViroGates announces its Annual Report 2024

Virogates
Regulatory press release3/19/2025, 5:46 PM

ViroGates announces an amendment to its agreement with Sobi

Virogates
Regulatory press release1/16/2025, 9:31 PM

ViroGates issues warrants to key employees

Virogates
Regulatory press release12/19/2024, 5:08 PM

ViroGates publishes its financial calendar for 2025

Virogates
Regulatory press release12/19/2024, 4:20 PM

ViroGates announces financial guidance for 2025

Virogates
Regulatory press release12/16/2024, 4:16 PM

ViroGates announces a reorganisation of its marketing and sales department and revises its guidance for the year

Virogates
Regulatory press release11/11/2024, 4:05 PM

ViroGates’ capital raise of DKK 8.2 million and issue of 1,289,510 new shares have been registered

Virogates
Regulatory press release11/7/2024, 11:05 AM

ViroGates announces its Interim Report for Q1-Q3 2024: Revenues are disappointing, but strategic refocusing will pave the way for future growth

Virogates
Regulatory press release10/14/2024, 4:37 PM

ViroGates announces a distribution agreement with suPAR Health and a directed issue of shares to suPAR Remedy LLC

Virogates
Regulatory press release8/15/2024, 10:30 AM

ViroGates announces its half-year report for H1 2024: Revenue for the first half-year of 2024 falls behind the same period in 2023 due to lower activity among research customers

Virogates
Regulatory press release7/17/2024, 12:45 PM

ViroGates announces revised financial guidance for 2024

Virogates
Regulatory press release5/2/2024, 9:20 AM

ViroGates announces its Interim Report for Q1, 2024: Quarterly revenue up 14% compared to Q1, 2023

Virogates
Regulatory press release4/25/2024, 6:29 PM

Resolutions from the Annual General Meeting of ViroGates A/S

Virogates
Regulatory press release4/15/2024, 4:36 PM

ViroGates announces the outcome of its Q-Submission filing for suPARnostic® TurbiLatex with the US FDA and the overall timeline for filing a submission of a 510k/“De Novo” application with the FDA

Virogates
Regulatory press release4/10/2024, 11:46 AM

ViroGates gives notice to convene the Annual General Meeting on 25 April 2024

Virogates
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team